Health and wellness advice, facts, and tips for living a well-balanced and comfortable lifestyle.

What is COPD, Nucala for COPD treatment

FDA Approves Nucala for COPD Patients with High Eosinophil Levels

The U.S. Food and Drug Administration (FDA) has approved Nucala (mepolizumab) as an add-on treatment for adults with chronic obstructive pulmonary disease (COPD) who continue to have flare-ups despite using triple inhaled therapy. Nucala is the first biologic drug specifically approved for COPD patients with an “eosinophilic phenotype”—a group defined by having high levels of

clinical trial myths

Clinical Trials: 5 Common Myths—Busted

Welcome to our series of blogs honoring Clinical Trials Day 2025, recognized on May 20th! Clinical trials are essential studies conducted to evaluate the safety, efficacy, and effectiveness of medical interventions, including drugs, treatments, devices, and diagnostic procedures. These trials follow a structured and rigorous process to generate reliable evidence for medical advancements, and to

RSV vaccine for seniors

New Study Shows RSV Vaccine Effective for Older Adults Over Three Seasons

A recent international study has found that a single dose of a new RSV vaccine, called RSVPreF3 OA, can protect adults aged 60 and older from serious lung infections caused by the respiratory syncytial virus (RSV) for up to three seasons.  The study involved over 24,000 older adults across 17 countries and tested how well

workplace coffee and cholesterol

Coffee Machines in Workplaces May Raise Cholesterol Levels, Study Finds

A recent study by Uppsala University and Chalmers University of Technology has found that coffee from many workplace coffee machines contains high levels of cholesterol-raising compounds. The research, published in Nutrition, Metabolism & Cardiovascular Diseases, highlights the difference between coffee brewed in these machines and coffee made using regular paper filter drip coffee makers.   

chronic kidney disease, Ozempic kidney disease approval

Ozempic Now Approved for Kidney Disease Treatment

The FDA has approved Novo Nordisk’s drug Ozempic for a new use: reducing the risk of kidney disease worsening, kidney failure, and death from cardiovascular disease in adults with Type 2 diabetes and chronic kidney disease (CKD). This approval is significant because Ozempic is now the first drug in its class (GLP-1 receptor agonists) with

Semaglutide weight loss

Novo Nordisk’s Higher-Dose Semaglutide Shows Promising Weight Loss Results

Novo Nordisk is exploring a higher-dose version of semaglutide to enhance weight loss treatments. In a recent phase 3b clinical trial called STEP UP, a 7.2-mg weekly dose of semaglutide helped participants lose an average of 20.7% of their body weight over 72 weeks. This significantly outperformed the 2.4-mg dose marketed as Wegovy, which led